Nektar Therapeutics (NKTR) Q1 2025 Earnings

12MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.25
-0.16
-0.06
0.03

Details

Expected EPS
-0.13561
Actual EPS
0.03
Surprise EPS
0.17
Surprise Percent
+122.12%

Description

Nektar Therapeutics (NKTR) has reported earnings of 0.03 per share for Q1 2025.

0 Comments

Share your thoughts